Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate

Journal of Biomaterials Science, Polymer Edition

Volumn 19, Issue 1, 2008, Pages 131-142

  Bi, Xiangdong ^a   Shi, Xiangyang ^b   Baker Jr , James R ^b  

^a CHARLESTON SOUTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

LHRH peptide; PAMAM dendrimer conjugate; Stability

Indexed keywords

AMINES; DRUG DELIVERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; SYNTHESIS (CHEMICAL); TUMORS;

BIOMEDICAL TARGETING; DENDRIMER CONJUGATE; POLYAMIDOAMINE;

DENDRIMERS;

DENDRIMER; GONADORELIN; PHOSPHATE BUFFERED SALINE; POLYAMIDOAMINE;

ARTICLE; DRUG CONJUGATION; DRUG SYNTHESIS; GENE TARGETING; IMAGING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

EID: 37849010278     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/156856208783227686     Document Type: Article

References (45)

1. P. Ehrlich, The Collected Papers of Paul Ehrlich. Pergamon, London (1956).
2. V. R. Sinha and R. Kumria, Int. J. Pharm. 224, 19 (2001).
3. P. S. Low and A. C. Antony, Adv. Drug. Deliv. Rev. 56, 1055 (2004).
4. M. J. Turka, D. J. Watersb and P. S. Low, Cancer Lett. 213, 165 (2004).
5. P. Houshmand and A. Zlotnik, Curr. Opin. Cell Biol. 15, 640 (2003).
6. W. G. Mao, E. Luis, S. Ross, J. Silva, C. Tan, C. Crowley, C. Chui, G. Franz, P. Senter, H. Koeppen and P. Polakis, Cancer Res. 64, 781 (2004).
7. M. Wirth, K. Gerhardt, C. Wurm and F. Gabor, J. Control. Rel. 79, 183 (2002).
8. H. Agadjanian, J. J. Weaver, A. Mahammed, A. Rentsendorj, S. Bass, J. Kim, I. J. Dmochowski, R. Margalit, H. B. Gray, Z. Gross and L. K. Medina-Kauwe, Pharm. Res. 23, 367 (2006).
9. Y. L. Yao and W. M. Yang, Curr. Cancer Drug Target. 5, 595 (2005).
10. O. H. Aina, T. C. Sroka, M. L. Chen and K. S. Lam, Biopolymers 66, 184 (2002).
11. L. A. Landon and S. L. Deutscher, J. Cell. Biochem. 90, 509 (2003).
12. R. A. Houghten, C. Pinilla, S. E. Blondelle, J. R. Appel, C. T. Dooley and J. H. Cuervo, Nature 354, 84 (1991).
13. A. V. Schally and A. Nagy, Eur. J. Endocrinol. 141, 1 (1999).
14. C. Fraschini, M. Jalabert and R. E. Prud'homme, Biomacromolecules 6, 3112 (2005).
15. A. M. Bajo, A. V. Schally, G. Halmos and A. Nagy, Clin. Cancer Res. 9, 3742 (2003).
16. A. Nagy and A. V. Schally, Biol. Reprod. 73, 851 (2005).
17. A. R. Gunthert, C. Grundker, T. Bongertz, T. Schlott, A. Nagy, A. V. Schally and G. Emons, Am. J. Obstetr. Gynecol. 191, 1164 (2004).
18. Y. H. Chu and B. T. Zhu, Life Sci. 57, 2031 (1995).
19. C. Grundker, Eur. J. Endocrinol. 143, 569 (2000).
20. J. B. Engel, G. Keller, A. V. Schally, A. Nagy, D. D. Chism and G. Halmos, Fertil. Steril. 83, 1125 (2005).
21. C. Leuschner, F. M. Enright, B. Gawronska-Kozak and W. Hanse, Prostate 56, 239 (2003).
22. A. Stangelberger, A. V. Schally, A. Nagy, K. Szepeshazi, C. A. Kanashiro and G. Halmos, Prostate 66, 220 (2006).
23. A. Plonowski, A. V. Schally, A. Nagy, K. Groot, M. Krupa, N. M. Navone and C. Logothetis, Cancer Lett. 176, 57 (2002).
24. G. Keller, A. V. Schally, T. Gaiser, A. Nagy, B. Baker, G. Halmos and J. B. Engel, Clin. Cancer Res. 11, 5549 (2005).
25. G. Keller, A. V. Schally, T. Gaiser, A. Nagy, B. Baker, G. Halmos and J. B. Engel, Eur. J. Cancer 41, 2196 (2005).
26. S. S. Dharap and T. Minko, Pharm. Res. 20, 889 (2003).
27. A. Nagy, A. V. Schally, P. Armatis, K. Szepeshazi, G. Halmos, M. Kovacs, M. Zarandi, K. Groot, M. Miyazaki, A. Jungwirth and J. Horvath, Proc. Natl. Acad. Sci. USA 93, 7269 (1996).
28. S. S. Dharap, B. Qiu, G. C. Williams, P. Sinko, S. Stein and T. Minko, J. Control. Rel. 91, 61 (2003).
29. S. S. Dharap, Y. Wang, P. Chandna, J. J. Khandare, B. Qiu, S. Gunaseelan, P. J. Sinko, S. Stein, A. Farmanfarmaian and T. Minko, Proc. Natl. Acad. Sci. USA 102, 12962 (2005).
30. T. Janaky, A. Juhasz, S. Bajusz, V. Csernus, G. Srkalovic, L. Bokser, S. Milovanovic, T. W. Redding, Z. Rekasi, A. Nagy and A. V. Schally, Proc. Natl. Acad. Sci. USA 89, 972 (1992).
31. J. Zhou, C. Leuschner, C. Kumar, J. F. Hormes and W. O. Soboyejo, Biomacromolecules 27, 2001 (2006).
32. T. P. Thomas, I. J. Majoros, A. Kotlyar, J. F. Kukowska-Latallo, A. Bielinska, A. Myc and J. R. Baker, J. Med. Chem. 48, 3729 (2005).
33. I. J. Majoros, T. P. Thomas, C. B. Mehta and J. R. Baker, J. Med. Chem. 48, 5892 (2005).
34. I. J. Majoros, A. Myc, T. Thomas, C. B. Mehta and J. R. Baker, Biomacromolecules 7, 572 (2006).
35. R. Shukla, T. P. Thomas, J. Peters, A. Kotlyar, A. Myc and J. R. Baker, Chem. Commun., 5739 (2005).
36. A. K. Patri, A. Myc, J. Beals, T. P. Thomas, N. H. Bander and J. R. Baker, Bioconjug. Chem. 15, 1174 (2004).
37. T. P. Thomas, A. K. Patri, A. Myc, M. T. Myaing, J. Y. Ye, T. B. Norris and J. R. Baker, Biomacromolecules 5, 2269 (2004).
38. F. Rage, D. F. Hill, M. Sena-Esteves, X. O. Breakefield, R. J. Coffey, M. E. Costa, S.M. McCann and S. R. Ojeda, Proc. Natl. Acad. Sci. USA 94, 2735 (1997).
39. F. Manabe, H. Takeshima, H. Akaza, Cancer 79, 1014 (2000).
40. A. Quintana, E. Raczka, L. Piehler, I. Lee, A. Myc, I. Majoros, A. K. Patri, T. Thomas, J. Mulé and J. R. J. Baker, Pharm. Res. 19, 1310 (2002).
41. I. J. Majoros, B. Keszler, S. Woehler, T. Bull and J. R. Baker, Macromolecules 36, 5526 (2003).
42. R. Esfand and D. A. Tomalia, Drug Discov. Today 6, 427 (2001).
43. I. J. Majoros, T. P. Thomas and J. R. Baker, in: Handbook of Theoretical and Computational Nanotechnology, p. 673, M. Rieth and W. Schommers (Eds). American Scietific Publishers, Valencia, CA (2006).
44. X. Shi, I. J. Majoros, A. K. Patri, X. D. Bi, M. T. Islam, A. Desai, R. Ganser and J. J. R. Baker, Analyst 131, 374 (2006).
45. E. K. Woller and M. J. Cloninger, Biomacromolecules 2, 1052 (2001).